AVE(SH:688067) Sou Hu Cai Jing·2025-05-12 11:49Company Overview - Awei Technology Co., Ltd. specializes in the research, development, production, sales, and service of medical clinical testing analysis instruments and in vitro diagnostic reagents, as well as medical consumables [1] - The company has developed a series of medical testing instruments based on original automatic microscopy technology, including automatic urine, feces, and reproductive tract secretion analyzers [1] Financial Performance - For Q1 2025, the company reported revenue of 53.30 million yuan, a year-on-year increase of 13.85%, and a net profit of 6.32 million yuan, up 24.63% year-on-year [2] - The sales gross margin for the company stands at 55.59% [2] Market Position - As of May 12, Awei Technology's stock closed at 19.98 yuan, with a rolling price-to-earnings (PE) ratio of 56.40, marking a new low in 36 days [1] - The average PE ratio for the medical device industry is 49.84, with a median of 36.59, placing Awei Technology at the 90th position in the industry ranking [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders for Awei Technology is 3,605, a decrease of 14 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]